CAS: 865200-20-0 - Giripladib
Formula:C41H36ClF3N2O4S
InChI:InChI=1/C41H36ClF3N2O4S/c42-33-22-23-37-35(26-33)34(16-9-10-28-18-20-31(21-19-28)40(48)49)38(47(37)39(29-11-3-1-4-12-29)30-13-5-2-6-14-30)24-25-46-52(50,51)27-32-15-7-8-17-36(32)41(43,44)45/h1-8,11-15,17-23,26,39,46H,9-10,16,24-25,27H2,(H,48,49)
- Synonyms:
- 4-(3-[5-Chloro-1-(diphenylmethyl)-2-[2-(((2-(trifluoromethyl)benzyl)sulfonyl)amino)ethyl]-1H-indole-3-yl]propyl)benzoic acid
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Giripladib REF: TM-T31929CAS: 865200-20-0 | 99.68% | 182.00 €~1,762.00 € | Tue 04 Jun 24 |
 | Giripladib REF: 3D-FG103776CAS: 865200-20-0 | Min. 95% | To inquire | Wed 12 Jun 24 |
 | Giripladib REF: TR-G388550CAS: 865200-20-0 | - - - | 17,836.00 € | Fri 12 Jul 24 |
Giripladib
CAS:865200-20-0
Giripladib (PLA695)(PLX-695) is a cPLA2-specific inhibitor that inhibits the radiation-induced increase of phosphorylated ERK and …
Formula:
C41H36ClF3N2O4S
Purity:
99.68%
Color and Shape:
Solid
Molecular weight:
745.25
Ref: TM-T31929
| 1mg | 182.00 € | |
| 5mg | 416.00 € | |
| 10mg | 611.00 € | |
| 25mg | 920.00 € | |
| 50mg | 1,286.00 € | |
| 100mg | 1,762.00 € | |
| 1ml*10 (DMSO) | 613.00 € |
Estimated delivery in United States, on Tuesday 4 Jun 2024
Giripladib
CAS:865200-20-0
Giripladib is an anti-angiogenic drug that inhibits the action of metalloproteases. The drug is a …
Formula:
C41H36ClF3N2O4S
Purity:
Min. 95%
Molecular weight:
745.25 g/mol
Ref: 3D-FG103776
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 12 Jun 2024
Ref: TR-G388550
| 75mg | 17,836.00 € |
Estimated delivery in United States, on Friday 12 Jul 2024
